Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Oncology Report

• Publication date

  2012-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2012.1853PMID 22684947
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epithelial ovarian cancer.

  2012cited by this paper
• Efficient inhibition of ovarian cancer by short hairpin RNA targeting claudin-3.

  2011cited by this paper
• Efficient Inhibition of Ovarian Cancer by Truncation Mutant of FILIP1L Gene Delivered by Novel Biodegradable Cationic Heparin-Polyethyleneimine Nanogels

  2011cited by this paper
• Selection of Drugs for Intraperitoneal Chemotherapy for Ovarian Cancer

  2010cited by this paper
• Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model

  2010cited by this paper
• A Combinatorial Approach for Targeted Delivery using Small Molecules and Reversible Masking to Bypass Non-Specific Uptake In Vivo

  2010cited by this paper
• Efficient inhibition of C-26 colon carcinoma by VSVMP gene delivered by biodegradable cationic nanogel derived from polyethyleneimine.

  2010cited by this paper
• Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure.

  2010cited by this paper
• Adeno-associated virus-mediated delivery of kringle 5 of human plasminogen inhibits orthotopic growth of ovarian cancer

  2010cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells--significant roles of CXCL10.

  2009cited by this paper
• Chemokine production and chemokine receptor expression by human glioma cells: role of CXCL10 in tumour cell proliferation.

  2008cited by this paper
• Efficient Inhibition of Ovarian Cancer Growth and Prolonged Survival by Transfection with a Novel Pro-Apoptotic Gene, hPNAS-4, in a Mouse Model

  2008cited by this paper
• HMGA2 gene is a promising target for ovarian cancer silencing therapy

  2008cited by this paper
• Arginine-chitosan/DNA self-assemble nanoparticles for gene delivery: In vitro characteristics and transfection efficiency.

  2008cited by this paper
• Progress in developing cationic vectors for non-viral systemic gene therapy against cancer.

  2008cited by this paper
• Progress in cationic lipid-mediated gene transfection: a series of bio-inspired lipids as an example.

  2008cited by this paper
• Dynamic progression of an intraperitoneal xenograft model of human ovarian cancer and its potential for preclinical trials.

  2007cited by this paper
• Efficient inhibition of intraperitoneal human ovarian cancer growth and prolonged survival by gene transfer of vesicular stomatitis virus matrix protein in nude mice.

  2007cited by this paper
• Tumour vascularization: sprouting angiogenesis and beyond

  2007cited by this paper
• A protocol for isolation and culture of human umbilical vein endothelial cells

  2007cited by this paper
• Opinion: Angiogenesis: an organizing principle for drug discovery?

  2007cited by this paper
• Angiogenesis: an organizing principle for drug discovery?

  2007cited by this paper
• Polyethylenimine-based non-viral gene delivery systems.

  2005cited by this paper
• Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives

  2005cited by this paper
• Antiangiogenic Therapy by Local Intracerebral Microinfusion Improves Treatment Efficiency and Survival in an Orthotopic Human Glioblastoma Model

  2004cited by this paper
• Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

  2004cited by this paper
• Nodal induces apoptosis and inhibits proliferation in human epithelial ovarian cancer cells via activin receptor-like kinase 7.

  2004cited by this paper
• Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.

  2003cited by this paper
• Angiogenesis and apoptosis.

  2003cited by this paper
• Genomewide view of gene silencing by small interfering RNAs

  2003cited by this paper
• Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine.

  2003cited by this paper
• Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin.

  2002cited by this paper
• Cationic lipid-DNA complexes-lipoplexes-for gene transfer and therapy.

  2002cited by this paper
• EPITHELIAL OVARIAN CANCER

  2002cited by this paper
• The promise and potential hazards of adenovirus gene therapy

  2001cited by this paper
• Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.

  2000cited by this paper
• Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.

  2000cited by this paper
• Lymphocyte‐specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization

  1998cited by this paper
• Mig and IP‐10: CXC chemokines that target lymphocytes

  1997cited by this paper
• The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily.

  1997cited by this paper
• A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells.

  1997cited by this paper
• The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*)

  1995cited by this paper
• A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.

  1995cited by this paper

• CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives

  2022cites this paper
• Identification of CXCL10-Relevant Tumor Microenvironment Characterization and Clinical Outcome in Ovarian Cancer

  2021cites this paper
• Elevated serum eotaxin and IP‐10 levels as potential biomarkers for the detection of esophageal squamous cell carcinoma

  2021cites this paper
• Cloning, Expression and One-Step Purification of a Novel IP-10-(anti-HER2 scFv) Fusion Protein in Escherichia coli

  2020cites this paper
• Advancement in the Biomedical Applications of the (Nano)gel Structures Based on Particular Polysaccharides.

  2019cites this paper
• Heparin-Based Nanoparticles: An Overview of Their Applications

  2018cites this paper
• Nanoparticles co-delivering pVSVMP and pIL12 for synergistic gene therapy of colon cancer

  2017cites this paper
• Heparin-Tailored Biopolymeric Nanocarriers in Site-Specific Delivery: A Systematic Review.

  2017cites this paper
• Acute changes in serum immune markers due to swimming in a chlorinated pool.

  2017cites this paper
• Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene

  2016cites this paper
• Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy

  2016cites this paper
• CXCR3 ligands in disease and therapy.

  2015cites this paper
• Identification of novel dipeptidyl peptidase 9 substrates by two‐dimensional differential in‐gel electrophoresis

  2015cites this paper
• Biodegradable Polymer Nanogels for Drug/Nucleic Acid Delivery.

  2015cites this paper
• Characterizing dsRNA-induced inflammation in ovarian cancer cells

  2014cites this paper
• CXCL10 mRNA expression predicts response to neoadjuvant chemoradiotherapy in rectal cancer patients

  2014cites this paper